Intermediate for Carfilzomib. Carfilzomib (trade name: Kyprolis) is an anti-cancer drug acting as a selective proteasome inhibitor. Carfilzomib has been approved by the U.S Food and Drug Administration on July 20, 2012.
Product Name: (2S)-2-Amino-4-methyl-1-((2R)-2-methyloxiranyl)-1-pentanone trifluoroacetate
CAS Number: 247068-85-5
Molecular Weight:  285.2627
Molecular Formula:  C11H18F3NO4
Purity (HPLC): ≥95%
Shipping Conditions: Room temperature.
Storage Conditions: Refrigerated.
Regulatory Statement:  For Research Use Only.
- Brands Tenova Pharmaceuticals
- Product Code: T31165
- Availability: In Stock
- Ex Tax: $554.00